TESARO Announces Acceptance for Review of Niraparib Marketing Authorization Application by EMA
Oct 27, 2016 20:10 pm UTC| Business
WALTHAM, Mass., Oct. 27, 2016 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Marketing Authorisation Application (MAA) for niraparib has been submitted to and...
Credit Acceptance Announces Completion of $350.0 Million Asset-Backed Financing
Oct 27, 2016 20:10 pm UTC| Business
Southfield, Michigan , Oct. 27, 2016 -- Credit Acceptance Corporation (NASDAQ: CACC) (the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today the completion of a $350.0 million asset-backed...
SPS Commerce Reports Third Quarter 2016 Financial Results
Oct 27, 2016 20:09 pm UTC| Business
MINNEAPOLIS, Oct. 27, 2016 -- SPS Commerce (NASDAQ:SPSC), a leader in retail cloud services, today announced financial results for the third quarter ended September 30, 2016. Revenue was $49.3 million in the third...
Otonomy to Report Third Quarter 2016 Financial Results and Provide Corporate Update
Oct 27, 2016 20:09 pm UTC| Business
SAN DIEGO, Oct. 27, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced it...
Vascular Solutions to Present at Upcoming Investor Conferences
Oct 27, 2016 20:09 pm UTC| Business
MINNEAPOLIS, Oct. 27, 2016 -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the company is scheduled to present at the Stifel 2016 Healthcare Conference in New York City on Wednesday, November 16th at...
Vascular Solutions to Present at Upcoming Investor Conferences
Oct 27, 2016 20:09 pm UTC| Business
MINNEAPOLIS, Oct. 27, 2016 -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the company is scheduled to present at the Stifel 2016 Healthcare Conference in New York City on Wednesday, November 16th at...
AV Homes Reports Results for Third Quarter 2016
Oct 27, 2016 20:09 pm UTC| Business
Third Quarter 2016 Highlights - as compared to the prior year third quarter (unless otherwise noted) Earnings per share increased 96% to $0.49, on net income of $11.9 million Total revenue increased 34% to $205.4...